The blood supply chain, from donor to patient: A call for greater understanding leading to more effective strategies for managing the blood supply

Transfusion

Volumn 43, Issue 2, 2003, Pages 132-134

  Jones, Robert L ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BLOOD DONOR; BLOOD FILTRATION; BLOOD SAMPLING; BLOOD TRANSFUSION; DEMOGRAPHY; EDITORIAL; ELASTICITY; FOOD AND DRUG ADMINISTRATION; PLASTICITY; PRACTICE GUIDELINE; RESPONSIBILITY; SAFETY; TERRORISM; UNITED STATES;

BLOOD BANKS; BLOOD DONORS; HUMANS; MASS SCREENING; MOTIVATION; RESOURCE ALLOCATION;

EID: 0037323007     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00346.x     Document Type: Editorial

References (17)

1. FDA Memorandum. Guidance for Industry. Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeld-Jacob Disease (CJD) and Variant Creutzfeld-Jacob Disease (vCJD) by Blood and Blood Products. January 2002.
2. Jones R, Davey R, Valinsky JE. Impact of the 9/11 disaster on blood donations in the New York area. Transfusion 2002;42S:115S.
3. Geyer ME. Recognition and retention: The evolution of September 11 blood donors and their commitment to give. Transfusion 2002;42S:125S.
4. Peterson C. 59% return rate for 9-11 donors provides a source for permanently increasing the donor base. Transfusion 2002;42S:127S.
5. Sullivan MT, Umana WO, Greer JI. Comprehensive report on blood collection and transfusion in the United States in 1999. Bethesda: The National Blood Data Resource Center, 2001.
6. Germain M, Remis RS, Delage G. The risks and benefits of accepting men who have had sex with men as blood donors. Transfusion 2003;43:25-33.
7. Schreiber GB, Glynn SA, Dameryn MA, et al. Lapsed donors: an untapped resource. Transfusion 2003;43:17-24.
8. Glynn SA, Williams AE, Nass CC, et al. Attitudes towards blood donation incentives in the United States: implications for donor recruitment. Transfusion 2003;43:7-16.
9. Simon T. Where have all the donors gone? A personal reflection on the crisis in America's volunteer blood program. Transfusion 2003;43:273-9.
10. Office of Regulatory Affairs Compliance References, US FDA. Compliance Policy Guide, Compliance Policy Guidance for FDA Staff and Industry, Chapter 2, Subchapter 230, Sec 230.150. Blood Donor Classification Statement, Paid or Volunteer Donor, 2002. Available online at URL: http://www.fda.gov/ora/compliance_ref/cpg/cpgbio/cpg230-150final.htm.
11. Rzaza M, Gilcher R. Cholesterol testing: incentive or health benefit? Transfusion 1988;28S:56S.
12. Bianco C, Brittenham G, Gilcher RO, et al. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002;42:798-805.
13. Rios M, Delman T, Valinsky JE. Prevalence of mutations associated with hereditary hemochromatosis (HHC) among blood donors. Transfusion 2002;42S:69S.
14. Meyers DG, Jensen KC, Menitove JE. Blood donation is associated with lower risk of cardiovascular events. Transfusion 2001;41S:35S.
15. Linden JV, Gregorio DI, Kalish RI. An estimate of blood donor eligibility in the general population. Vox Sang 1988;54:96-100.
16. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against. Transfusion 2001;41:692-712.
17. Workshop on Safety and Efficacy of Methods for Reducing Pathogens in Cellular Blood Products. Center for Biologic Evaluation and Research Food and Drug Administration. 2002 Aug 7-8, Bethesda.